While mutations in BRCA1 are less penetrant, patients carrying BRCA2 germline mutations are linked to a significantly higher risk of developing PCa and are more likely to progress to advanced stages of the disease. This evidence concerns the gene BRCA1 and posterior cortical atrophy.